{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:20:21Z","timestamp":1774916421083,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2575-6","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T01:28:55Z","timestamp":1499995735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Economic burden of varicella in children 1\u201312\u00a0Years of age in Hungary, 2011\u20132015"],"prefix":"10.1186","volume":"17","author":[{"given":"Z.","family":"Meszner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rampakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara J.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"3","key":"2575_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","volume":"9","author":"AM Arvin","year":"1996","unstructured":"Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361\u201381.","journal-title":"Clin Microbiol Rev"},{"key":"2575_CR2","unstructured":"Whitley, R.J., Varicella-zoster virus infections, R.J.W. G. J. Galasso, and T. C. Merigan, Editor. 2012, Raven Press: New York. p. 235\u2013263."},{"issue":"2","key":"2575_CR3","first-page":"99","volume":"19","author":"R Manfredi","year":"1997","unstructured":"Manfredi R, et al. Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-chickenpox Italian study group. Pediatr Med Chir. 1997;19(2):99\u2013104.","journal-title":"Pediatr Med Chir"},{"issue":"6","key":"2575_CR4","first-page":"614","volume":"53","author":"H Ozdemir","year":"2011","unstructured":"Ozdemir H, et al. Chickenpox complications, incidence and financial burden in previously healthy children and those with an underlying disease in Ankara in the pre-vaccination period. Turk J Pediatr. 2011;53(6):614\u201325.","journal-title":"Turk J Pediatr"},{"issue":"5","key":"2575_CR5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.5.e79","volume":"108","author":"C Ziebold","year":"2001","unstructured":"Ziebold C, et al. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatr. 2001;108(5):E79.","journal-title":"Pediatr"},{"issue":"12","key":"2575_CR6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","volume":"31","author":"A Bardach","year":"2012","unstructured":"Bardach A, et al. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean-a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31(12):1263\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"9544","key":"2575_CR7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2575_CR8","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1086\/522163","volume":"197","author":"C Sadzot-Delvaux","year":"2008","unstructured":"Sadzot-Delvaux C, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197(Suppl 2):S185\u201390.","journal-title":"J Infect Dis"},{"key":"2575_CR9","unstructured":"EUVAC.net . Varicella Surveillance report 2010. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/varicella_report_2010_euvacnet.pdf . Accessed 2016."},{"key":"2575_CR10","unstructured":"ORSZ\u00c1GOS EPIDEMIOL\u00d3GIAI K\u00d6ZPONT. A hazai j\u00e1rv\u00e1ny\u00fcgyi helyzet \u00e1ltal\u00e1nos jellemz\u00e9se (Epinfo 22. \u00e9vfolyam 51\u201353. sz\u00e1m). 2016. http:\/\/epa.oszk.hu\/00300\/00398\/00664\/pdf\/EPA00398_epinfo_2015_51-53.pdf . Accessed 2016."},{"issue":"45","key":"2575_CR11","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866\u201372.","journal-title":"Vaccine"},{"key":"2575_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.epidem.2014.12.005","volume":"11","author":"E Santermans","year":"2015","unstructured":"Santermans E, et al. The social contact hypothesis under the assumption of endemic equilibrium: elucidating the transmission potential of VZV in Europe. Epidemics. 2015;11:14\u201323.","journal-title":"Epidemics"},{"key":"2575_CR13","unstructured":"K\u00f6zponti Statisztikai Hivatal. 2015. https:\/\/www.ksh.hu\/docs\/eng\/xstadat\/xstadat_annual\/i_wnt001b.html . Accessed 2016."},{"key":"2575_CR14","doi-asserted-by":"crossref","unstructured":"Meszner, Z., et al., The Potential Public Health Impact of Varicella Vaccination in Hungary. Poster (PIN93) presented at: ISPOR 19th annual European congress; 2016; Vienna, Austria.","DOI":"10.1016\/j.jval.2016.09.444"},{"key":"2575_CR15","unstructured":"Az Eg\u00e9szs\u00e9g\u00fcgyi Miniszt\u00e9rium szakmai ir\u00e1nyelve. A varicella kezel\u00e9s\u00e9r\u0151l \u00e9s megel\u0151z\u00e9s\u00e9r\u0151l. 2008. http:\/\/www.kk.pte.hu\/docs\/protokollok\/INFEKTVaricella_kezelesehez_P.pdf ."},{"issue":"4 Pt 2","key":"2575_CR16","first-page":"748","volume":"78","author":"AM Arbeter","year":"1986","unstructured":"Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78(4 Pt 2):748\u201356.","journal-title":"Pediatrics"},{"issue":"4","key":"2575_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","volume":"127","author":"PR Krause","year":"1995","unstructured":"Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr. 1995;127(4):518\u201325.","journal-title":"J Pediatr"},{"issue":"9","key":"2575_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","volume":"9","author":"BJ Kuter","year":"1991","unstructured":"Kuter BJ, et al. Oka\/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991;9(9):643\u20137.","journal-title":"Vaccine"},{"issue":"22","key":"2575_CR19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","volume":"310","author":"RE Weibel","year":"1984","unstructured":"Weibel RE, et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N. Engl. J Med. 1984;310(22):1409\u201315.","journal-title":"N. Engl. J Med"},{"issue":"5","key":"2575_CR20","first-page":"604","volume":"87","author":"CJ White","year":"1991","unstructured":"White CJ, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics. 1991;87(5):604\u201310.","journal-title":"Pediatrics"},{"issue":"5","key":"2575_CR21","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","volume":"131","author":"R Baxter","year":"2013","unstructured":"Baxter R, et al. Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study. Pediatrics. 2013;131(5):e1389\u201396.","journal-title":"Pediatrics"},{"issue":"7","key":"2575_CR22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","volume":"294","author":"F Zhou","year":"2005","unstructured":"Zhou F, et al. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797\u2013802.","journal-title":"JAMA"},{"issue":"9","key":"2575_CR23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/INF.0b013e318260cc4d","volume":"31","author":"B Tan","year":"2012","unstructured":"Tan B, et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatr Infect Dis J. 2012;31(9):956\u201363.","journal-title":"Pediatr Infect Dis J"},{"key":"2575_CR24","unstructured":"ORSZ\u00c1GOS EPIDEMIOL\u00d3GIAI K\u00d6ZPONT. M\u00f3dszertani lev\u00e9l a 2013. \u00e9vi v\u00e9d\u0151olt\u00e1sokr\u00f3l (Epinfo 20. \u00e9vfolyam 1. k\u00fcl\u00f6nsz\u00e1m). http:\/\/www.oek.hu\/oek.web?nid=444&pid=1 . Accessed 2016."},{"key":"2575_CR25","first-page":"97","volume":"3","author":"S L\u00e1szl\u00f3","year":"2013","unstructured":"L\u00e1szl\u00f3 S, et al. Varicella vaccination in Hungary and Poland: optimization of public benefits from prophylaxis technologies in the time of austerity. New Med. 2013;3:97\u2013102.","journal-title":"New Med"},{"key":"2575_CR26","unstructured":"OECD.stat. 2015. https:\/\/stats.oecd.org \/. Accessed 2016."},{"issue":"2","key":"2575_CR27","first-page":"119","volume":"48","author":"GM Ginsberg","year":"2004","unstructured":"Ginsberg GM, Somekh E. Cost containment analysis of childhood vaccination against varicella in Israel. J Inf Secur. 2004;48(2):119\u201333.","journal-title":"J Inf Secur"},{"issue":"1 Pt 1","key":"2575_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.104.1.1","volume":"104","author":"B Law","year":"1999","unstructured":"Law B, et al. Cost of chickenpox in Canada: part I. Cost of uncomplicated cases. Pediatrics. 1999;104(1 Pt 1):1\u20136.","journal-title":"Pediatrics"},{"key":"2575_CR29","unstructured":"European Central Bank. 2016. https:\/\/www.ecb.europa.eu\/stats\/exchange\/eurofxref\/html\/eurofxref-graph-huf.en.html . Accessed 2016."},{"issue":"5","key":"2575_CR30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00006454-199905000-00004","volume":"18","author":"P Fornaro","year":"1999","unstructured":"Fornaro P, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian sentinel group on pediatric infectious diseases. Pediatr Infect Dis J. 1999;18(5):414\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2575_CR31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4161\/hv.9897","volume":"5","author":"A Iseli","year":"2009","unstructured":"Iseli A, et al. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin. 2009;5(12):843\u20136.","journal-title":"Hum Vaccin"},{"issue":"5","key":"2575_CR32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1469-0691.2004.00853.x","volume":"10","author":"S Wagenpfeil","year":"2004","unstructured":"Wagenpfeil S, et al. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect. 2004;10(5):425\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2575_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","volume":"101","author":"S Blumental","year":"2016","unstructured":"Blumental S, et al. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016;101(1):16\u201322.","journal-title":"Arch Dis Child"},{"issue":"2","key":"2575_CR34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","volume":"27","author":"JG Liese","year":"2008","unstructured":"Liese JG, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27(2):119\u201324.","journal-title":"Pediatr Infect Dis J"},{"key":"2575_CR35","first-page":"226","volume":"2","author":"O Turel","year":"2013","unstructured":"Turel O, et al. Children hospitalized for varicella: complications and cost burden. ViHRI. 2013;2:226\u201330.","journal-title":"ViHRI"},{"issue":"23","key":"2575_CR36","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1016\/S0264-410X(03)00264-0","volume":"21","author":"J Diez-Domingo","year":"2003","unstructured":"Diez-Domingo J, et al. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. Vaccine. 2003;21(23):3236\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"2575_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","volume":"191","author":"P Wutzler","year":"2002","unstructured":"Wutzler P, et al. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol. 2002;191(2):89\u201396.","journal-title":"Med Microbiol Immunol"},{"key":"2575_CR38","doi-asserted-by":"crossref","unstructured":"Arama, V., et al., Varicella in Romania: epidemiological trends, 1986\u20132004. Euro Surveill, 2005. 10(8): p. E050811 6.","DOI":"10.2807\/esw.10.32.02775-en"},{"issue":"4","key":"2575_CR39","first-page":"282","volume":"3","author":"JC Bramley","year":"2000","unstructured":"Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000;3(4):282\u20137.","journal-title":"Commun Dis Public Health"},{"issue":"1","key":"2575_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0950268806006467","volume":"135","author":"F Dubos","year":"2007","unstructured":"Dubos F, et al. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135(1):131\u20138.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"2575_CR41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","volume":"165","author":"M Theodoridou","year":"2006","unstructured":"Theodoridou M, et al. Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr. 2006;165(4):273\u20134.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2575_CR42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1651-2227.2007.00595.x","volume":"97","author":"V Grote","year":"2008","unstructured":"Grote V, et al. Varicella-related deaths in children and adolescents--Germany 2003-2004. Acta Paediatr. 2008;97(2):187\u201392.","journal-title":"Acta Paediatr"},{"issue":"5","key":"2575_CR43","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","volume":"13","author":"E Grimprel","year":"2007","unstructured":"Grimprel E, et al. Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect. 2007;13(5):546\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"2575_CR44","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1016\/j.ijid.2012.11.024","volume":"17","author":"E Gowin","year":"2013","unstructured":"Gowin E, Wysocki J, Michalak M. Don't forget how severe varicella can be--complications of varicella in children in a defined polish population. Int J Infect Dis. 2013;17(7):e485\u20139.","journal-title":"Int J Infect Dis"},{"key":"2575_CR45","unstructured":"European Centre for Disease Prevention and Control (ECDC). Varicella vaccination in the European Union. 2015 [cited 2017; Available from: http:\/\/ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1253 ."},{"issue":"Suppl 1","key":"2575_CR46","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","volume":"70","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol. 2003;70(Suppl 1):S9\u201314.","journal-title":"J Med Virol"},{"issue":"6623","key":"2575_CR47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.296.6623.673","volume":"296","author":"CA Joseph","year":"1988","unstructured":"Joseph CA, Noah ND. Epidemiology of chickenpox in England and Wales, 1967-85. Br Med J (Clin Res Ed). 1988;296(6623):673\u20136.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"9","key":"2575_CR48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0929-693X(04)00410-5","volume":"11","author":"E Mallet","year":"2004","unstructured":"Mallet E, et al. Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France. Arch Pediatr. 2004;11(9):1145\u201351.","journal-title":"Arch Pediatr"},{"issue":"10","key":"2575_CR49","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1651-2227.2007.00465.x","volume":"96","author":"S Marchetto","year":"2007","unstructured":"Marchetto S, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr. 2007;96(10):1490\u20133.","journal-title":"Acta Paediatr"},{"issue":"6","key":"2575_CR50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","volume":"164","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164(6):366\u201370.","journal-title":"Eur J Pediatr"},{"key":"2575_CR51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-13-303","volume":"13","author":"A Streng","year":"2013","unstructured":"Streng A, et al. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian varicella surveillance project (BaVariPro), 2006-2011. BMC Infect Dis. 2013;13:303.","journal-title":"BMC Infect Dis"},{"key":"2575_CR52","unstructured":"T\u00f3th, E., et al., The disease burden of varicella in Hungary. IPSOR. 2012. http:\/\/www.healthware.hu\/files\/public\/ISPOR_Varicella_COI_2012.pdf . Accessed 2016."},{"key":"2575_CR53","unstructured":"OANDA Corporation. 2016. https:\/\/www.Oanda.Com\/currency\/average . Accessed 2016. 2016."},{"issue":"47\u201348","key":"2575_CR54","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2006.04.051","volume":"24","author":"X Lenne","year":"2006","unstructured":"Lenne X, et al. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine. 2006;24(47\u201348):6980\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"2575_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1524-4733.2005.04005.x","volume":"8","author":"L Coudeville","year":"2005","unstructured":"Coudeville L, et al. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005;8(3):209\u201322.","journal-title":"Value Health"},{"key":"2575_CR56","unstructured":"The World Bank. Health expenditure per capita (current US$). 2013. http:\/\/data.worldbank.org\/indicator\/SH.XPD.PCAP . Accessed 2016."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2575-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T23:36:23Z","timestamp":1659224183000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2575-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2575"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2575-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"article-number":"495"}}